The clinically approved antiviral drug sofosbuvir inhibits Zika virus replicationCarolina Q. Sacramento, Thiago Moreno L. Souza, Lucas Villas Bôas Hoelz et al.|Scientific Reports|2017Cited by 243
Sepsis is a major determinant of outcome in critically ill HIV/AIDS patientsAndré Miguel Japiassú, Fernando A. Bozza, Rodrigo T. Amâncio et al.|Critical Care|2010Cited by 101